thiethylperazine has been researched along with Acute Disease in 3 studies
Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.
Acute Disease: Disease having a short and relatively severe course.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahlerup, B | 1 |
Hostrup-Pedersen, C | 1 |
Engbaek, J | 1 |
Richter, HR | 1 |
Briellmann, A | 1 |
3 other studies available for thiethylperazine and Acute Disease
Article | Year |
---|---|
[Acute facial dyskinesia after treatment with thiethylperazine (Torecan)].
Topics: Acute Disease; Administration, Oral; Adolescent; Biperiden; Dyskinesia, Drug-Induced; Face; Female; | 1976 |
[Acute dyskinesia in children treated with thiethylperazine (Torecan)].
Topics: Acute Disease; Child; Humans; Movement Disorders; Thiethylperazine; Vertigo | 1975 |
[Acute dyskinesia following short-term antiemetic medication].
Topics: Acute Disease; Adult; Diagnosis, Differential; Female; Humans; Movement Disorders; Prochlorperazine; | 1969 |